| # | Drug | Count |
|---|---|---|
| 0 | APIXABAN | 2 |
| 1 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 1 |
| 2 | CAPECITABINE | 1 |
| 3 | CLOZAPINE | 1 |
| 4 | IBRUTINIB | 1 |
| 5 | PACLITAXEL | 1 |
| 6 | PACLITAXEL (AIBUMIN-BOUND) | 1 |
| 7 | PEMBROLIZUMAB | 1 |
| 8 | RAMUCIRUMAB | 1 |
| 9 | RITUXIMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 1 | 0.0004 |
| 1 | RAMUCIRUMAB | 1 | 0.0002 |
| 2 | APIXABAN | 2 | 0.0000 |
| 3 | IBRUTINIB | 1 | 0.0000 |
| 4 | CAPECITABINE | 1 | 0.0000 |
| 5 | PACLITAXEL | 1 | 0.0000 |
| 6 | PEMBROLIZUMAB | 1 | 0.0000 |
| 7 | CLOZAPINE | 1 | 0.0000 |
| 8 | RITUXIMAB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthracycline Topoisomerase Inhibitor [EPC] | 1 | 0.0004 |
| 1 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Factor Xa Inhibitor [EPC] | 2 | 0.0000 |
| 5 | Microtubule Inhibitor [EPC] | 1 | 0.0000 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 7 | Atypical Antipsychotic [EPC] | 1 | 0.0000 |
| 8 | Kinase Inhibitor [EPC] | 1 | 0.0000 |